查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832287

生物聚合物市场（按类型、製程类型、应用和最终用途产业）—2025-2032 年全球预测

Biopolymers Market by Type, Process Type, Application, End Use Industry - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年生物聚合物市场将成长至 520.9 亿美元，复合年增长率为 14.06%。

主要市场统计数据
基准年2024年 181.7亿美元
预计2025年 207.6亿美元
预测年份：2032年 520.9亿美元
复合年增长率（%） 14.06%

简要说明不断发展的生物聚合物格局、框架材料创新、监管状况以及决策者的商业性优先事项

生物聚合物产业正处于永续性目标、材料科学进步和不断变化的法律规范的交汇点，这些因素正在重塑产业对聚合物及其循环利用的认知。近年来，原料采购、聚合物化学和废弃物处理途径的创新推动了生物聚合物从小众应用领域迈向包装、医疗、纺织和汽车领域的主流应用。随着价值链上相关人员致力于减少碳足迹并提高生物降解性，其技术和商业性格局持续快速演变。

本执行摘要概述了影响采购、产品设计和政策参与的策略曲折点。它强调了支撑需求的转型变化、关税带来的政策阻力，以及决定生物聚合物在哪些领域获得竞争优势的微妙细分市场动态。透过将技术属性与应用层面的需求连结起来，本分析旨在为决策者提供关于风险、机会和战术性槓桿的清晰视角。

展望未来，将材料创新与务实的供应链弹性、循环产品设计和有针对性的监管参与相结合的公司将最有能力将其永续性承诺转化为永续的商业性优势。本摘要的其余部分提取了关键转变、细分见解、区域差异以及为行业领导者推荐的策略行动。

日益严格的法规、原料多样化和工程突破如何重塑生物聚合物领域的材料选择、供应链和商业性伙伴关係

生物聚合物的市场格局正在发生重大变化，这源于许多压力，包括永续性需求的提升、聚合物性能的提升以及终端用户期望的变化。针对一次性塑胶和报废产品揭露的监管愈发严格，促使各大品牌优先选择具有可靠生物降解性和工业可堆肥性的材料。同时，共聚、相容剂和阻隔涂层技术的进步，使负责人能够缩小与石化基聚合物的性能差距，使其在高要求应用中广泛应用。

同时，原料多样化正在减少对第一代农业投入的依赖，并强调废弃物衍生糖、新型微生物途径和化学回收中间体。这种转变支持了更强的循环论点，并降低了商品波动带来的风险。此外，生产规模的改进，包括製程强化和原料预处理创新，正在减少生产瓶颈并提高下游相容性。

综上所述，这些转变正在为产品团队和采购部门带来新的考虑：如今，材料的选择需要兼顾环保资质、射出成型和挤出等製程的加工相容性，以及从医疗设备到柔性薄膜等各种应用的最终使用性能。因此，材料供应商、加工商和品牌商之间的合作关係正变得更加策略性和长期性，体现出一体化的价值创造而非交易型采购。

了解 2025 年美国关税变化对整个生物聚合物价值链的筹资策略、区域投资和供应链弹性的策略影响

美国宣布的2025年关税政策为生物聚合物价值链的参与者带来了新的商业性考量，既带来了成本压力，也带来了在地化或重新配置采购的策略奖励。关税调整正在影响诸如聚合设施的选址、如何建立长期供应合约以及是否进行原料加工的垂直整合等决策。因此，许多相关人员正在重新评估其供应商组合，以降低跨境关税波动带来的风险，同时保持特种化学品的供应。

为应对这项挑战，一些製造商和加工商加快了对区域产能扩张和产能共用协议的投资，以维持前置作业时间并维持即时供应模式。同时，依赖进口的加工商寻求对冲策略和更灵活的合约量，以在不影响客户价格稳定的情况下吸收关税的转嫁影响。这些调整也影响了资本配置，显着转向模组化、扩充性的工厂，这些工厂可以部署在更靠近主要终端市场的地方，从而最大限度地降低关税的影响。

重要的是，企业正在平衡关税减免与其他优先事项，例如成分永续性、生命週期声明和工艺适用性。因此，一些公司在短期内接受了更高的到岸成本，以确保获得支持更强大品牌定位的生物基和认证成分。展望未来，关税制度将继续影响策略决策，领导团队需要将贸易政策情境规划纳入其商业和业务蓝图，以保持竞争力。

深度细分洞察，将聚合物类型、加工方法、应用和最终用途行业要求联繫起来，揭示可操作的材料和製造重点

細項分析揭示了性能属性、加工相容性和最终用途要求的融合点，从而在整个生物聚合物产业中创造出差异化的价值提案。按类型划分，纤维素、PBAT、PBS、PCL、PHA、PLA 和淀粉衍生聚合物各自在生物降解性、机械性能和热行为方面具有不同的平衡性，这使得某些聚合物更适合用于薄膜、软包装和医疗设备。根据製程类型，材料流变性和热稳定性的变化决定了其是否适用于 3D 列印、吹塑成型、射出成型和热成型，进而影响转换设备的选择和週期经济性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 用于永续食品包装的奈米纤维素纤维增强生物基 PLA 复合材料的开发
  • 海藻多醣衍生的海洋可降解生质塑胶在柔性薄膜的研究进展
  • 高分子量生物PET替代品的酵素聚合路线的实现
  • 整合微生物发酵製程生产客製化聚羟基烷酯
  • 扩大木质素基热塑性化合物用于永续汽车内装零件
  • 生物聚合物薄膜工业可堆肥性的监管协调和认证标准
  • 使用藻类衍生的生物聚合物进行生物医学支架製造的 3D 列印细丝的创新

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：生物聚合物市场（按类型）

  • 纤维素
  • Polybutylene Adipate Terephthalate（PBAT）
  • Polybutylene Succinate（PBS）
  • 聚己内酯（PCL）
  • 聚羟基烷酯（PHA）
  • 聚乳酸（PLA）
  • 淀粉

9. 按製程类型分類的生物聚合物市场

  • 3D列印
  • 吹塑成型
  • 压缩成型
  • 挤压
  • 吹膜
  • 射出成型
  • 热成型

第十章生物聚合物市场（依应用）

  • 农业
    • 控释系统
    • 多部电影
  • 车
    • 外部零件
    • 内装零件
  • 消费品
    • 家居用品
    • 个人保养用品
  • 电子产品
    • 套管
    • 连接器
  • 药品
    • 药物输送
    • 医疗设备
  • 包裹
    • 电影
    • 软包装
    • 硬质包装
  • 纤维
    • 纤维
    • 不织布

第 11 章：生物聚合物市场（依最终用途产业）

  • 农业
  • 车
  • 家电
    • 套管
    • 连接器
  • 消费品
  • 饮食
  • 医疗保健和医学
    • 医疗设备
    • 医药包装
  • 纤维

第十二章生物聚合物市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章生物聚合物市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章 各国生物聚合物市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • NatureWorks LLC
    • Corbion NV
    • BASF SE
    • DuPont de Nemours, Inc.
    • Evonik Industries AG
    • TotalEnergies Corbion BV
    • Braskem SA
    • Arkema SA
    • Royal DSM NV
    • Eastman Chemical Company
Product Code: MRR-437D45957B93

The Biopolymers Market is projected to grow by USD 52.09 billion at a CAGR of 14.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 18.17 billion
Estimated Year [2025] USD 20.76 billion
Forecast Year [2032] USD 52.09 billion
CAGR (%) 14.06%

A concise orientation to the evolving biopolymers landscape that frames material innovation, regulatory momentum, and commercial priorities for decision-makers

The biopolymers sector sits at the confluence of sustainability ambitions, material science advances, and shifting regulatory frameworks, reshaping how industries conceive of polymers and their circularity. In recent years, innovation in feedstock sourcing, polymer chemistry, and end-of-life pathways has moved biopolymers from niche applications into mainstream consideration across packaging, medical, textiles, and automotive domains. As stakeholders across value chains pursue lower carbon footprints and enhanced biodegradability, the technology and commercial landscape continues to evolve rapidly.

This executive summary synthesizes the strategic inflection points influencing procurement, product design, and policy engagement. It highlights the transformative shifts underpinning demand, the policy headwinds emanating from tariff actions, and the nuanced segmentation dynamics that determine where biopolymers will gain competitive advantage. By bridging technical characteristics with application-level requirements, the analysis aims to equip decision-makers with a coherent view of risk, opportunity, and tactical levers.

Looking ahead, companies that integrate materials innovation with pragmatic supply chain resilience, circular product design, and targeted regulatory engagement will be best positioned to convert sustainability commitments into durable commercial advantage. The remainder of this summary distills the critical shifts, segmentation insights, regional differentials, and recommended strategic actions for industry leaders.

How regulatory tightening, feedstock diversification, and engineering breakthroughs are reshaping material selection, supply chains, and commercial partnerships within the biopolymers sector

The landscape for biopolymers is undergoing transformative shifts driven by converging pressures: escalating sustainability requirements, improvements in polymer performance, and changing end-user expectations. Regulatory regimes are tightening around single-use plastics and end-of-life disclosures, prompting brands to prioritize materials that deliver verified biodegradability or industrial compostability. At the same time, formulators have narrowed the performance gap with petrochemical-based polymers through advances in copolymerization, compatibilizers, and barrier coatings, enabling broader adoption in demanding applications.

In parallel, feedstock diversification has reduced reliance on first-generation agricultural inputs, with increasing emphasis on waste-derived sugars, novel microbial pathways, and chemically recycled intermediates. This transition supports more robust claims around circularity and diminishes exposure to commodity volatility. Moreover, manufacturing-scale improvements, including process intensification and feedstock pretreatment innovations, have lowered production bottlenecks and improved downstream processing compatibility.

Taken together, these shifts create a new calculus for product teams and procurement functions: material selection now balances environmental credentials, processing compatibility across methods such as injection molding and extrusion, and end-use performance in applications ranging from medical devices to flexible films. Consequently, alliances between material suppliers, converters, and brand owners are becoming more strategic and longer-term, reflecting integrated value creation rather than transactional sourcing.

Understanding the strategic ripple effects of United States tariff changes in 2025 on sourcing strategies, regional investments, and supply chain resilience across biopolymer value chains

United States tariff policy announced for 2025 has introduced a new layer of commercial consideration for participants in the biopolymers value chain, creating both cost pressures and strategic incentives to localize or reconfigure sourcing. Tariff adjustments have influenced decisions about where to site polymerization facilities, how to structure long-term supply contracts, and whether to pursue vertical integration into feedstock processing. As a result, many stakeholders are reassessing supplier portfolios to mitigate exposure to cross-border tariff volatility while preserving access to specialized chemistries.

In response, several manufacturers and converters have accelerated investment in regional capacity expansions and capacity-sharing agreements to preserve lead times and maintain just-in-time supply models. At the same time, import-dependent converters have explored hedging approaches and more flexible contracted volumes to absorb tariff pass-through without destabilizing customer pricing. These adaptations have implications for capital allocation, with a noticeable shift toward modular, scalable plants that can be deployed closer to major end-use markets to minimize tariff impacts.

Crucially, companies are balancing tariff mitigation with other priorities such as feedstock sustainability, lifecycle claims, and processing compatibility. Consequently, some firms have accepted higher landed costs in the short term to secure biobased or certified feedstocks that underpin stronger brand positioning. Going forward, tariff regimes will continue to influence strategic decisions, and leadership teams must integrate trade-policy scenario planning into their commercial and operational roadmaps to maintain competitiveness.

Deep segmentation insights linking polymer type, processing method, application demands, and end-use industry requirements to reveal actionable material and manufacturing priorities

Segmentation analysis reveals where performance characteristics, processing compatibility, and end-use requirements converge to create differentiated value propositions across the biopolymers landscape. Based on Type, cellulose-based materials, PBAT, PBS, PCL, PHA, PLA, and starch-derived polymers each offer distinct balances of biodegradability, mechanical properties, and thermal behavior, making certain polymers preferable for films, flexible packaging, or medical devices. Based on Process Type, variations in material rheology and thermal stability determine suitability for 3D printing, blow molding, compression molding, extrusion, film blowing, injection molding, and thermoforming, which in turn shape converter equipment choices and cycle economics.

Based on Application, agriculture, automotive, consumer goods, electronics, medical, packaging, and textiles present unique performance and regulatory constraints. For instance, agriculture applications such as controlled release systems and mulch films demand predictable degradation profiles and minimal ecotoxicity, whereas automotive exterior and interior components require UV resistance and dimensional stability. Consumer goods span household products and personal care items that prioritize tactile properties and regulatory compliance. Electronics applications like casings and connectors emphasize flame retardancy and dielectric properties, while medical use cases for drug delivery and medical devices require rigorous biocompatibility and sterilization compatibility. Packaging variants-films, flexible packaging, and rigid packaging-differ in barrier performance and recyclability considerations. Textiles deployed as fibers or nonwovens must balance tensile strength, dyeability, and end-of-life pathways.

Based on End Use Industry, agriculture, automotive, consumer electronics, consumer goods, food & beverage, healthcare & medical, and textiles drive divergent specification demands and procurement cycles. Consumer electronics components such as casings and connectors impose tight dimensional tolerances and thermal requirements, whereas healthcare and medical end uses require materials validated for medical devices and pharmaceutical packaging. Integrating these segmentation lenses highlights where formulation adjustments, processing investments, and certification roadmaps will most effectively align materials to market needs.

Regional dynamics shaping feedstock access, regulatory incentives, and infrastructure readiness that determine adoption trajectories for biopolymers across global markets

Geographic dynamics materially influence feedstock availability, regulatory incentives, and adoption timelines, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, a combination of agricultural feedstock access and evolving procurement priorities is driving investments in both fermentation-based and chemically derived biopolymers, while state and federal policy signals shape infrastructure funding for composting and industrial processing. As a result, manufacturers increasingly evaluate North American plants as strategic nodes for serving regional demand where policy support aligns with brand commitments.

Europe, Middle East & Africa exhibits pronounced regulatory leadership on single-use plastics and labeling, which accelerates adoption of certified biodegradable materials and circular packaging solutions. Producer responsibility frameworks and composting infrastructure are particularly influential in shaping which biopolymers gain traction for municipal and industrial waste streams. Conversely, the Asia-Pacific region combines rapid industrial demand with cost-sensitive manufacturing ecosystems, prompting large-scale capacity investments and a focus on improving process efficiencies to meet both domestic and export markets. Feedstock innovation in Asia-Pacific is also notable, with increasing attention to waste-to-feedstock pathways that reduce reliance on virgin agricultural inputs.

Taken together, these regional distinctions imply that material developers and converters must calibrate product portfolios, certification strategies, and supply footprints to regional regulatory regimes, waste-management capabilities, and end-customer expectations. Cross-regional partnerships and technology transfer agreements will become critical for scaling solutions that must meet diverse compliance and performance benchmarks.

Competitive positioning and strategic partnerships that define leaders in biopolymer innovation, supply reliability, and circularity-enabled value creation

The competitive landscape is characterized by a mix of established chemical companies, specialized biopolymer producers, and agile startups that are redefining supply chains and application ecosystems. Legacy chemical producers are leveraging scale and polymer expertise to broaden their biopolymer portfolios, integrating upstream feedstock processing and downstream compounding to offer converters materials with more consistent performance. Simultaneously, specialized biopolymer firms and innovators are differentiating through niche performance attributes, sustainability certifications, and targeted applications such as medical-grade resins or compostable packaging solutions.

Partnerships and strategic collaborations are prominent, often pairing material developers with converters and brand owners to co-develop formulations that meet specific processing and end-use requirements. Contract manufacturing arrangements and tolling models are increasingly used to accelerate market entry while managing capital intensity. At the same time, some players are vertically integrating into feedstock sourcing or recycling operations to secure circular inputs and improve margin visibility. Investment activity favors companies that demonstrate reproducible performance in regulated applications and those that can provide robust lifecycle documentation.

Overall, competitive advantage is accruing to organizations that combine material science leadership with demonstrable supply reliability, transparent sustainability credentials, and the ability to support converters with processing know-how. The most successful firms are those that invest in application support, scale-appropriate manufacturing, and certification pathways to reduce adoption friction for downstream customers.

Actionable strategic steps for industry leaders to integrate material innovation, supply resilience, and credible sustainability verification into commercial roadmaps

Industry leaders should prioritize integrated strategies that align material innovation with operational resilience, regulatory engagement, and customer-centric value propositions. First, companies must accelerate collaboration across the value chain-material suppliers, converters, and brand owners should co-develop formulations optimized for targeted processing routes and end-of-life systems to minimize reformulation cycles and accelerate commercialization. Concurrently, investment in modular production assets can reduce sensitivity to trade disruptions and tariff shifts while enabling local responsiveness to demand patterns.

Second, firms need to embed rigorous sustainability verification and product stewardship into commercial offerings. This includes transparent lifecycle assessments, third-party certifications where applicable, and clear end-of-life guidance tailored to regional waste infrastructure. By contrast, vague environmental claims will increasingly erode trust and invite regulatory scrutiny. Third, organizations should pursue a pragmatic feedstock diversification strategy that balances cost, scalability, and circularity benefits; exploring waste-derived inputs and scalable fermentation routes will be essential to secure long-term raw material availability.

Finally, sales and product teams must align go-to-market strategies with segment-level requirements-medical and electronics customers demand higher validation and longer qualification cycles, while packaging and consumer goods often prioritize cost-to-performance and supply security. Executing these recommendations will require coordinated capital planning, cross-functional capability development, and proactive regulatory monitoring to translate sustainability mandates into competitive differentiation.

A transparent methodological approach combining stakeholder interviews, technical literature, and lifecycle assessment frameworks to validate trend analysis and strategic implications

This analysis synthesizes primary qualitative inputs and secondary technical literature to ensure robust, reproducible findings. Primary research consisted of structured interviews with material scientists, converters, brand procurement leads, and waste-management specialists to capture practical constraints around processing, certification, and end-of-life management. Interview protocols emphasized scenario-based questions to understand how stakeholders balance performance trade-offs, supply risk, and sustainability claims in procurement and product design decisions.

Secondary research incorporated peer-reviewed literature, patent landscape reviews, regulatory filings, and publicly available corporate disclosures to triangulate trends in feedstock innovation, process improvements, and certification pathways. Lifecycle assessment methodologies and standardized test protocols were consulted to evaluate biodegradation claims and application suitability. Where possible, cross-validation between primary and secondary evidence was used to reduce bias and to surface divergent viewpoints that inform risk assessment.

Analytical rigor was preserved through methodology transparency, iterative validation with domain experts, and sensitivity checks on qualitative assumptions. Limitations include reliance on available public technical data for emerging chemistries and variable regional data granularity for waste infrastructure. These caveats have been considered in framing strategic recommendations and scenario implications for decision-makers.

Concluding synthesis that ties material innovation, regulatory realities, and operational preparedness into a pragmatic roadmap for capturing sustainable commercial value

The biopolymers sector is at a pivotal juncture where technological maturity, regulatory momentum, and commercial imperatives intersect to create substantive opportunity for materials that can demonstrably reduce environmental impact while meeting application-specific performance standards. Stakeholders that act decisively-investing in scalable manufacturing, aligning product claims with credible verification, and forging cross-sector partnerships-will realize the most durable advantages. Conversely, those that rely on unverified claims or fail to integrate processing and end-of-life realities will face adoption barriers and reputational risk.

In summary, the path forward requires an integrated approach that balances innovation with pragmatic deployment. Material selection should be guided by a clear understanding of processing compatibility and end-of-life pathways, while strategic investments should prioritize flexible capacity and feedstock diversification. By doing so, companies can navigate tariff uncertainties, regional infrastructure differences, and evolving regulatory expectations to convert sustainability commitments into measurable business outcomes.

The subsequent sections of this report provide deeper technical appendices, scenario planning tools, and implementation guides to translate these high-level conclusions into actionable project roadmaps for engineering, procurement, and commercial teams.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of bio-based PLA composites reinforced with nanocellulose fibers for sustainable food packaging
  • 5.2. Advances in marine biodegradable bioplastics derived from seaweed polysaccharides for flexible films
  • 5.3. Implementation of enzymatic polymerization routes for high-molecular-weight bio-PET alternatives
  • 5.4. Integration of microbial fermentation processes for tailored polyhydroxyalkanoate copolymer production
  • 5.5. Scaling up of lignin-based thermoplastic formulations for sustainable automotive interior components
  • 5.6. Regulatory harmonization and certification standards for industrial compostability of biopolymer films
  • 5.7. Innovations in 3D printing filaments using algae-sourced biopolymers for biomedical scaffold fabrication

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopolymers Market, by Type

  • 8.1. Cellulose
  • 8.2. Polybutylene Adipate Terephthalate (PBAT)
  • 8.3. Polybutylene Succinate (PBS)
  • 8.4. Polycaprolactone (PCL)
  • 8.5. Polyhydroxyalkanoates (PHA)
  • 8.6. Polylactic Acid (PLA)
  • 8.7. Starch

9. Biopolymers Market, by Process Type

  • 9.1. 3D Printing
  • 9.2. Blow Molding
  • 9.3. Compression Molding
  • 9.4. Extrusion
  • 9.5. Film Blowing
  • 9.6. Injection Molding
  • 9.7. Thermoforming

10. Biopolymers Market, by Application

  • 10.1. Agriculture
    • 10.1.1. Controlled Release Systems
    • 10.1.2. Mulch Films
  • 10.2. Automotive
    • 10.2.1. Exterior Components
    • 10.2.2. Interior Components
  • 10.3. Consumer Goods
    • 10.3.1. Household Products
    • 10.3.2. Personal Care Items
  • 10.4. Electronics
    • 10.4.1. Casings
    • 10.4.2. Connectors
  • 10.5. Medical
    • 10.5.1. Drug Delivery
    • 10.5.2. Medical Devices
  • 10.6. Packaging
    • 10.6.1. Films
    • 10.6.2. Flexible Packaging
    • 10.6.3. Rigid Packaging
  • 10.7. Textiles
    • 10.7.1. Fibers
    • 10.7.2. Nonwoven

11. Biopolymers Market, by End Use Industry

  • 11.1. Agriculture
  • 11.2. Automotive
  • 11.3. Consumer Electronics
    • 11.3.1. Casings
    • 11.3.2. Connectors
  • 11.4. Consumer Goods
  • 11.5. Food & Beverage
  • 11.6. Healthcare & Medical
    • 11.6.1. Medical Devices
    • 11.6.2. Pharmaceutical Packaging
  • 11.7. Textiles

12. Biopolymers Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biopolymers Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biopolymers Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. NatureWorks LLC
    • 15.3.2. Corbion N.V.
    • 15.3.3. BASF SE
    • 15.3.4. DuPont de Nemours, Inc.
    • 15.3.5. Evonik Industries AG
    • 15.3.6. TotalEnergies Corbion BV
    • 15.3.7. Braskem S.A.
    • 15.3.8. Arkema SA
    • 15.3.9. Royal DSM N.V.
    • 15.3.10. Eastman Chemical Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPOLYMERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPOLYMERS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPOLYMERS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPOLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPOLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPOLYMERS MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPOLYMERS MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPOLYMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIOPOLYMERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIOPOLYMERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIOPOLYMERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIOPOLYMERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPOLYMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPOLYMERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPOLYMERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPOLYMERS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPOLYMERS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPOLYMERS MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPOLYMERS MARKET SIZE, BY CELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPOLYMERS MARKET SIZE, BY CELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPOLYMERS MARKET SIZE, BY CELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPOLYMERS MARKET SIZE, BY CELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPOLYMERS MARKET SIZE, BY CELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE (PBAT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE (PBAT), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE (PBAT), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE (PBAT), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE (PBAT), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE ADIPATE TEREPHTHALATE (PBAT), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE SUCCINATE (PBS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE SUCCINATE (PBS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE SUCCINATE (PBS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE SUCCINATE (PBS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE SUCCINATE (PBS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYBUTYLENE SUCCINATE (PBS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATES (PHA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATES (PHA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATES (PHA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATES (PHA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATES (PHA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATES (PHA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPOLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPOLYMERS MARKET SIZE, BY STARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPOLYMERS MARKET SIZE, BY STARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPOLYMERS MARKET SIZE, BY STARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPOLYMERS MARKET SIZE, BY STARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPOLYMERS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPOLYMERS MARKET SIZE, BY STARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPOLYMERS MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPOLYMERS MARKET SIZE, BY 3D PRINTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPOLYMERS MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPOLYMERS MARKET SIZE, BY 3D PRINTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPOLYMERS MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPOLYMERS MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPOLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPOLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPOLYMERS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPOLYMERS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPOLYMERS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPOLYMERS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPOLYMERS MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPOLYMERS MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPOLYMERS MARKET SIZE, BY COMPRESSION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPOLYMERS MARKET SIZE, BY COMPRESSION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPOLYMERS MARKET SIZE, BY COMPRESSION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPOLYMERS MARKET SIZE, BY COMPRESSION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILM BLOWING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILM BLOWING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILM BLOWING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILM BLOWING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILM BLOWING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILM BLOWING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPOLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPOLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPOLYMERS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPOLYMERS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPOLYMERS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPOLYMERS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPOLYMERS MARKET SIZE, BY THERMOFORMING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPOLYMERS MARKET SIZE, BY THERMOFORMING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPOLYMERS MARKET SIZE, BY THERMOFORMING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPOLYMERS MARKET SIZE, BY THERMOFORMING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPOLYMERS MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPOLYMERS MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPOLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPOLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPOLYMERS MARKET SIZE, BY MULCH FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPOLYMERS MARKET SIZE, BY MULCH FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPOLYMERS MARKET SIZE, BY MULCH FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPOLYMERS MARKET SIZE, BY MULCH FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPOLYMERS MARKET SIZE, BY MULCH FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPOLYMERS MARKET SIZE, BY MULCH FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTERIOR COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTERIOR COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTERIOR COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTERIOR COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTERIOR COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPOLYMERS MARKET SIZE, BY EXTERIOR COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPOLYMERS MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPOLYMERS MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPOLYMERS MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPOLYMERS MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPOLYMERS MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPOLYMERS MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOPOLYMERS MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOPOLYMERS MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOPOLYMERS MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOPOLYMERS MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOPOLYMERS MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOPOLYMERS MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOPOLYMERS MARKET SIZE, BY PERSONAL CARE ITEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOPOLYMERS MARKET SIZE, BY PERSONAL CARE ITEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOPOLYMERS MARKET SIZE, BY PERSONAL CARE ITEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOPOLYMERS MARKET SIZE, BY PERSONAL CARE ITEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOPOLYMERS MARKET SIZE, BY PERSONAL CARE ITEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOPOLYMERS MARKET SIZE, BY PERSONAL CARE ITEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOPOLYMERS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOPOLYMERS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOPOLYMERS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOPOLYMERS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOPOLYMERS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOPOLYMERS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOPOLYMERS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOPOLYMERS MARKET SIZE, BY FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOPOLYMERS MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOPOLYMERS MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOPOLYMERS MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOPOLYMERS MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOPOLYMERS MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOPOLYMERS MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOPOLYMERS MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOPOLYMERS MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOPOLYMERS MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOPOLYMERS MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOPOLYMERS MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOPOLYMERS MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOPOLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOPOLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOPOLYMERS MARKET SIZE, BY FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOPOLYMERS MARKET SIZE, BY FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOPOLYMERS MARKET SIZE, BY FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOPOLYMERS MARKET SIZE, BY FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIOPOLYMERS MARKET SIZE, BY NONWOVEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIOPOLYMERS MARKET SIZE, BY NONWOVEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIOPOLYMERS MARKET SIZE, BY NONWOVEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIOPOLYMERS MARKET SIZE, BY NONWOVEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIOPOLYMERS MARKET SIZE, BY NONWOVEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIOPOLYMERS MARKET SIZE, BY NONWOVEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIOPOLYMERS MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIOPOLYMERS MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIOPOLYMERS MARKET SIZE, BY CASINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONNECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIOPOLYMERS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIOPOLYMERS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIOPOLYMERS MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIOPOLYMERS MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIOPOLYMERS MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIOPOLYMERS MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL BIOPOLYMERS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL BIOPOLYMERS MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL BIOPOLYMERS MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL BIOPOLYMERS MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL BIOPOLYMERS MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL BIOPOLYMERS MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL BIOPOLYMERS MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL BIOPOLYMERS MARKET SIZE, BY TEXTILES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL BIOPOLYMERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL BIOPOLYMERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS BIOPOLYMERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS BIOPOLYMERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS BIOPOLYMERS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS BIOPOLYMERS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. AMERICAS BIOPOLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. AMERICAS BIOPOLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. AMERICAS BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 324. AMERICAS BIOPOLYMERS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 325. AMERICAS BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, 2018-2024 (USD MILLION)
  • TABLE 326. AMERICAS BIOPOLYMERS MARKET SIZE, BY AUTOMOTIVE, 2025-2032 (USD MILLION)
  • TABLE 327. AMERICAS BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, 2018-2024 (USD MILLION)
  • TABLE 328. AMERICAS BIOPOLYMERS MARKET SIZE, BY CONSUMER GOODS, 2025-2032 (USD MILLION)
  • TABLE 329. AMERICAS BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, 2018-2024 (USD MILLION)
  • TABLE 330. AMERICAS BIOPOLYMERS MARKET SIZE, BY ELECTRONICS, 2025-2032 (USD MILLION)
  • TABLE 331. AMERICAS BIOPOLYMERS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 332. AMERICAS BIOPOLYMERS MARKET SIZE, BY MEDICAL, 2025-2032 (USD MILLION)
  • TABLE 333. AMERICAS BIOPOLYMERS MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 334. AMERICAS BIOPOLYMERS MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 335. AMERICAS BIOPOLYMERS MARKET SIZE, BY TEXTILES, 2018-2024 (USD MILLION)
  • TABLE 336. AMERICAS BIOPOLYMERS MARKET SIZE, BY TEXTILES, 2025-2032 (USD MILLION)
  • TABLE 337. AMERICAS BIOPOLYMERS MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 338. AMERICAS BIOPOLYMERS MARKET SIZE, BY END USE INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 339. AMERICAS BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, 2018-2024 (USD MILLION)
  • TABLE 340. AMERICAS BIOPOLYMERS MARKET SIZE, BY CONSUMER ELECTRONICS, 2025-2032 (USD MILLION)
  • TABLE 341. AMERICAS BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 342. AMERICAS BIOPOLYMERS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2025-2032 (USD MILLION)
  • TABLE 343. NORTH AMERICA BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 344. NORTH AMERICA BIOPOLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 345. NORTH AMERICA BIOPOLYMERS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. NORTH AMERICA BIOPOLYMERS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. NORTH AMERICA BIOPOLYMERS MARKET SIZE, BY PROCESS TYPE, 2018-20